热灭活(灭活生物体），NR-1_Vaccinia virus

产品基础信息

生物安全等级建议分类：美国、1

产品描述信息

NR-56495??SARS-Related Coronavirus 2, Isolate hCoV-19/USA/GA-EHC-2811C/2021 (Lineage B.1.1.529; Omicron Variant), Heat Inactivated(Inactivated Organisms)|SARS-Related Coronavirus 2|Isolate hCoV-19/USA/GA-EHC-2811C/2021 (Lineage B.1.1.529; Omicron Variant), Heat Inactivated| -60°C or colder |M SutharAcknowledgment for publications should read "The following reagent was obtained through BEI Resources, NIAID, NIH: SARS-Related Coronavirus 2, Isolate hCoV-19/USA/GA-EHC-2811C/2021 (Lineage B.1.1.529; Omicron Variant), Heat Inactivated, NR-56495."|Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment. Due to the high volume of orders, NIAID will prioritize shipments.

NR-56495 is a preparation of severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2), isolate hCoV-19/USA/GA-EHC-2811C/2021 that has been inactivated by heating to 65°C for 30 minutes and diluted prior to vialing.

SARS-CoV-2, isolate hCoV-19/USA/GA-EHC-2811C/2021 was isolated from a mid-turbinate swab from a vaccinated patient with travel history from Africa/South Africa on December 1, 2021, in Georgia, USA.

Each vial contains approximately 0.25 mL of heat inactivated, clarified and diluted cell lysate and supernatant from Homo sapiens lung adenocarcinoma epithelial cells (Calu-3; ATCC ^? HTB-55?) infected with SARS-CoV-2, isolate hCoV-19/USA/GA-EHC-2811C/2021. The vial should be centrifuged prior to opening.

Note: The long-term stability of this preparation is not known at this time. It is recommended that users confirm the activity of the product if not used within three months of receipt. You may also contact BEI Resources for updated stability information.

主要内容

此项目的每个订单数量限制为1.此商品每年可订购两次.在此限制上订单将在发货前发送至NIAID进行批准.由于秩序量大，野核将优先发货. NR-56495是一种制备严重的急性呼吸综合征相关的冠状病毒2（SARS-COV-2），分离HCOV-19 / USA / GA-EHC-2811C / 2021，其通过加热至65℃而已灭活30分钟在瓶中之前稀释. SARS-COV-2，分离型HCOV-19 / USA / GA-EHC-2811C / 2021在2021年12月1日，从非洲/南非的旅游历史的疫苗患者中分离出从中鼻甲拭子中分离出来的，在美国佐治亚州. 每个小瓶含有大约0.25ml的热灭活，澄清和稀释的细胞裂解物和来自均匀胰蛋白酶的上清液肺腺癌上皮细胞（Calu-3; ATCC ? HTB-55?）用SARS-COV-2感染，分离物HCOV-19 / USA / GA-EHC-2811C / 2021.小瓶应在开放前离心. 注意：此时不知道该准备的长期稳定性.建议用户在收到三个月内使用，确认产品的活动.您还可以联系Bei资源进行更新的稳定信息.

厂牌介绍

BEI Resources 由美国国家过敏和传染病研究所 ( NIAID )成立，旨在为研究 A、B 和 C 类优先病原体、新兴传染病病原体、非病原微生物和其他相关微生物材料提供试剂、工具和信息到研究界。BEI Resources 获取、验证和生产科学家进行基础研究和开发改进的诊断测试、疫苗和疗法所需的试剂。通过将这些功能集中在 BEI Resources 中，可以监控科学界对这些材料的访问和使用，并确保试剂的质量控制。

除了为传染病界提供材料外，BEI Resources 还鼓励和支持研究人员和机构的材料存放。使用 BEI Resources存放材料对研究人员和研究社区有许多优势，包括安全存储、社区访问和分发；同时保护存款人的知识产权。只要有需要，BEI 资源库将作为研究人员的资源进行维护。您在 BEI Resources 的存款是一项有助于未来研究的长期投资。

BEI Resources 自 2003 年起由美国典型培养物保藏中心 (ATCC) 根据合同管理。2016 年 5 月， ATCC获得了一份为期七年的继续管理 BEI Resources的合同。合同范围已扩大到更全面的研究目录材料，包括由其他政府支持的研究项目存放的材料，将提供给生物防御和新兴传染病科学界。真菌、寄生虫、载体和其他相关材料已添加到现有的细菌、病毒和毒素试剂中，涵盖 NIAID A、B 和 C 类优先病原体和 NIAID 指定的新发传染病病原体和生物。

品牌标识

产品关键词

分离物 hCoV-19/USA/GA-EHC-2811C/2021(谱系 B.1.1.529；Omicron 变体）

NR-56495 SARS 相关冠状病毒 2

一键获取大包装优惠报价

报价要求详细描述

贵单位贵姓

接受报价的E-mail

手机扫描二维码阅读本页

可能感兴趣的内容

2022-04-01

NR-47909金黄色葡萄球菌亚种.金黄色葡萄球菌,USA300JE2,转座子突变体SAUSA300_0137(NE1367)(突变细菌）

2021-12-13

2022-04-01

2024-06-05

2023-08-31

2022-04-01

2022-04-01

2022-04-01

2022-04-01

2022-04-01

2024-08-04

2022-04-01

2024-01-21

2021-12-21

2022-04-01

2024-11-17

2022-03-22

2024-02-29

CY5 DBCO,10毫克

2021-12-21

2021-10-31

NR-56128_SARS相关冠状病毒2,分离hCoV-19/USA/MD-HP05285/2021(谱系B.1.617.2；Delta变体）,热灭活(灭活生物体）

NR-56128_ SARS-Related Coronavirus 2, Isolate hCoV-19/USA/MD-HP05285/2021 (Lineage B.1.617.2; Delta Variant), Heat Inactivated(Inactivated Organisms)

产品图片

产品英文名称

产品别名

NR-56128_ SARS-Related Coronavirus 2, Isolate hCoV-19/USA/MD-HP05285/2021 (Lineage B.1.617.2; Delta Variant), Heat Inactivated(Inactivated Organisms)
NR-56128_ SARS 相关冠状病毒 2，分离 hCoV-19/USA/MD-HP05285/2021（谱系 B.1.617.2；Delta 变体），热灭活（灭活生物体）

货号/SKU

NR-56128

货号/规格

库存与交货期

3-8周

人民币价格

14000

人民币价格说明

本商品人民币2024年销售价格正在调整中，请等待更新完毕。

本商品的美元价、市场价、零售价、厂商指导价或该商品的曾经展示过的销售价等，并非商品原价，仅供参考。

试剂海关审批

A/B级风险物质只能直接使用人购买并持有实验室有效资质，其它询客服确认

国外采购

支持/部分限制一年内购买数量

厂牌

BEI Resources(ATCC)

品牌

产品基础信息

生物安全等级建议分类：美国、1

产品描述信息

NR-56128?? SARS-Related Coronavirus 2, Isolate hCoV-19/USA/MD-HP05285/2021 (Lineage B.1.617.2; Delta Variant), Heat Inactivated(Inactivated Organisms)|SARS-Related Coronavirus 2|SARS-Related Coronavirus 2, Isolate hCoV-19/USA/MD-HP05285/2021 (Lineage B.1.617.2; Delta Variant), Heat Inactivated|-60°C or colder|AS PekoszAcknowledgment for publications should read "The following reagent was obtained through BEI Resources, NIAID, NIH: SARS-Related Coronavirus 2, Isolate hCoV-19/USA/MD-HP05285/2021 (Lineage B.1.617.2; Delta Variant), Heat Inactivated, NR-56128."|Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment.

NR-56128 is recommend for molecular assays. The current quality control testing for this item does not include immunological assays and it is not recommended that NR-56128 be used in this manner.

NR-56128 is a preparation of severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2), isolate hCoV-19/USA/MD-HP05285/2021 that has been inactivated by heating to 65°C for 30 minutes and diluted prior to vialing.

SARS-CoV-2, isolate hCoV-19/USA/MD-HP05285/2021 was isolated from a human in Maryland, USA on April 26, 2021.

The complete genome of the clinical isolate of SARS-CoV-2, hCoV-19/USA/MD-HP05285/2021 has been sequenced (GISAID: EPI_ISL_2103264).

Intended Use:
NR-56128 is primarily intended for use in molecular assays or can be used as a process (work-flow) control (for example: viral RNA extraction through qPCR amplification process). Please refer to the Certificate of Analysis for pre-inactivation infectious titer and post-inactivated genome equivalence (GE) quantification by Droplet Digital PCR for your specific lot. The GE is determined by full and partial genomes and is an estimate for end-users to qualify assays on their platform and is subject to efficiency of RNA extraction. The estimated GE can also be used to make a dilution series to estimate level of detection. The heat inactivation procedure is known to damage viral RNA and large fragments are not easily amplified. The suitability of this product as a whole cell antigen preparation has not been assessed and may be influenced by the protein content largely contributed by the host cell and the fetal bovine serum used during virus propagation.

Inactivation Procedure:
Please refer to the Certificate of Analysis for the inactivation testing details.

Each vial contains approximately 0.25 mL of heat inactivated, clarified and diluted cell lysate and supernatant from Homo sapiens lung adenocarcinoma epithelial cells (Calu-3; ATCC ^? HTB-55?) cells infected with SARS-CoV-2, isolate hCoV-19/USA/MD-HP05285/2021. The vial should be centrifuged prior to opening.

Note: The long-term stability of this preparation is not known at this time. It is recommended that users confirm the activity of the product if not used within three months of receipt. You may also contact BEI Resources for updated stability information.

主要内容

此项目的每个订单数量限制为1.此商品每年可订购两次.通过此限制的订单将在发货前发送至NIAID进行批准. 推荐NR-56128用于分子测定.该项目的当前质量控制测试不包括免疫测定，不建议以这种方式使用NR-56128. NR-56128是一种制备严重急性呼吸综合征相关的冠状病毒2（SARS-COV-2），分离HCOV-19 / USA / MD-HP05285 / 2021，其通过加热至65℃而灭活30分钟并稀释在瓶中之前. SARS-COV-2，孤立的HCOV-19 / USA / MD-HP05285 / 2021于4月26日从美国马里兰州的人类分离出来，20021年4月26日. SARS-COV-2的临床分离株的完整基因组（GISAID：EPI_ISL_2103264）. NR-56128主要用于分子测定或者可以用作过程（工作流程）控制（例如：病毒RNA 通过QPCR扩增过程提取）.请参阅证书灭活前传染性滴度和后灭活基因组分析液滴数码PCR为您的特定批次量化等价物（GE）量化. GE由完整和部分基因组决定，是估计最终用户符合其平台上的测定，并符合效率 RNA提取.估计的GE也可用于制造稀释系列估计检测水平.众所周知，热灭活程序损坏病毒RNA和大片段不易扩增. 本品作为全细胞抗原的适用性准备有未评估，可能受蛋白质含量的影响在很大程度上由宿主细胞和胎儿牛血清贡献病毒繁殖. 灭活程序：请参阅分析证书用于灭活测试细节. 每个小瓶含有大约0.25ml的热灭活，澄清和稀释的细胞裂解物和来自均匀胰蛋白酶的上清液肺腺癌上皮细胞（Calu-3; ATCC ? HTB-55?）用SARS-COV-2感染细胞，分离HCOV-19 / USA / MD-HP05285 / 2021.小瓶应在开放前离心. 注意：此时不知道该准备的长期稳定性.建议用户在收到三个月内使用，确认产品的活动.您还可以联系Bei资源进行更新的稳定信息.

厂牌介绍

品牌标识

产品关键词

分离 hCoV-19/USA/MD-HP05285/2021(谱系 B.1.617.2；Delta 变体）

NR-56128_ SARS 相关冠状病毒 2

一键获取大包装优惠报价

报价要求详细描述

贵单位贵姓

接受报价的E-mail

手机扫描二维码阅读本页

可能感兴趣的内容

2022-04-01

NR-47909金黄色葡萄球菌亚种.金黄色葡萄球菌,USA300JE2,转座子突变体SAUSA300_0137(NE1367)(突变细菌）

2021-12-13

2022-04-01

2024-06-05

2023-08-31

2022-04-01

2022-04-01

2022-04-01

2022-04-01

2022-04-01

2024-08-04

2022-04-01

2024-01-21

2021-12-21

2022-04-01

2024-11-17

2022-03-22

2024-02-29

CY5 DBCO,10毫克

2021-12-21

2021-10-31

NR-55245_SARS相关冠状病毒2,隔离USA/CA_CDC_5574/2020,热灭活(灭活生物体）

NR-55245_SARS-Related Coronavirus 2, Isolate USA/CA_CDC_5574/2020, Heat Inactivated(Inactivated Organisms)

产品图片

产品英文名称

产品别名

NR-55245_SARS-Related Coronavirus 2, Isolate USA/CA_CDC_5574/2020, Heat Inactivated(Inactivated Organisms)
NR-55245_SARS 相关冠状病毒 2，隔离 USA/CA_CDC_5574/2020，热灭活（灭活生物体）

货号/SKU

NR-55245

货号/规格

库存与交货期

3-8周

人民币价格

14000

人民币价格说明

本商品人民币2024年销售价格正在调整中，请等待更新完毕。

本商品的美元价、市场价、零售价、厂商指导价或该商品的曾经展示过的销售价等，并非商品原价，仅供参考。

试剂海关审批

A/B级风险物质只能直接使用人购买并持有实验室有效资质，其它询客服确认

国外采购

支持/部分限制一年内购买数量

厂牌

BEI Resources(ATCC)

品牌

产品基础信息

生物安全等级建议分类：美国、1

产品描述信息

NR-55245??SARS-Related Coronavirus 2, Isolate USA/CA_CDC_5574/2020, Heat Inactivated(Inactivated Organisms)|SARS-Related Coronavirus 2|Isolate USA/CA_CDC_5574/2020, Heat Inactivated|-60°C or colder|CDCAcknowledgment for publications should read "The following reagent was deposited by the Centers for Disease Control and Prevention and obtained through BEI Resources, NIAID, NIH: SARS-Related Coronavirus 2, Isolate USA/CA_CDC_5574/2020, Heat Inactivated, NR-55245."|Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment.

NR-55245 is recommend for molecular assays. The current quality control testing for this item does not include immunological assays and it is not recommended that NR-55245 be used in this manner.

NR-55245 is a preparation of severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2), isolate USA/CA_CDC_5574/2020 that has been inactivated by heating to 65°C for 30 minutes and diluted prior to vialing.

SARS-CoV-2, isolate USA/CA_CDC_5574/2020 was isolated from a nasopharyngeal swab on December 29, 2020 in San Diego County, California, USA.

Under the nomenclature system introduced by GISAID (Global Initiative on Sharing All Influenza Data), SARS-CoV-2, isolate USA/CA_CDC_5574/2020 is assigned lineage B.1.1.7 and GISAID clade GR using Phylogenetic Assignment of Named Global Outbreak LINeages (PANGOLIN) tool. The complete genome of SARS-CoV-2, isolate USA/CA_CDC_5574/2020 has been sequenced (GISAID: EPI_ISL_751801).

Intended Use:
NR-55245 is intended for use in molecular assays or can be used as a process (work-flow) control (for example: viral RNA extraction through qPCR amplification process). Please refer to the Certificate of Analysis for pre-inactivation infectious titer and post-inactivated genome equivalence (GE) quantification by Droplet Digital PCR for your specific lot. The GE is determined by full and partial genomes and is an estimate for end-users to qualify assays on their platform. The quantified products can also be used to make a dilution series to estimate level of detection. However, this product is not suitable as a whole cell antigen preparation because the protein content is largely contributed by the host cell and the fetal bovine serum used during virus propagation.

Inactivation Procedure:
Please refer to the Certificate of Analysis for the inactivation testing for the lot of material you have obtained from BEI Resources. In brief, 10% of the lot of inactivated virus is tested to confirm the absence of residual live virus by inoculating host cells. Using suitable controls, the test sample is passaged twice, with each passage incubated for two weeks. During procedure development, the inactivation protocol was validated by testing 100% of the sample of three independent lots for residual live virus. Note: The heat inactivation procedure is known to damage viral RNA and large fragments are not easily amplified. This material is suitable for qPCR assays for detection of small genome fragments.

Each vial contains approximately 0.25 mL of heat inactivated, clarified and diluted cell lysate and supernatant from Vero E6 cells infected with SARS-CoV-2, isolate USA/CA_CDC_5574/2020. The vial should be centrifuged prior to opening.

Note: The long-term stability of this preparation is not known at this time. It is recommended that users confirm the activity of the product if not used within three months of receipt. You may also contact BEI Resources for updated stability information.

主要内容

此项目的每个订单数量限制为1.此商品每年可订购两次.通过此限制的订单将在发货前发送至NIAID进行批准. 推荐NR-55245用于分子测定.该项目的当前质量控制测试不包括免疫系统，建议不要以这种方式使用NR-55245. NR-55245是重症急性呼吸综合征相关的冠状病毒2（SARS-COV-2）的制备，分离USA / CA_CDC_5574 / 2020，其通过加热至65℃而已灭活30分钟并在瓶中稀释. SARS-COV-2，孤立USA / CA_CDC_5574 / 2020于2020年12月29日在美国加利福尼亚州圣地亚哥县的鼻咽拭子中分离出来. 根据GISAID引入的命名系统（全球共享所有流感数据的倡议），SARS-COV-2，隔离USA / CA_CDC_5574 / 2020分配了使用名为全球爆发谱系的系统发育分配的谱系B.1.1.7和GISAID CLADE GR（ Pangolin）工具. SARS-COV-2的完整基因组，隔离USA / CA_CDC_5574 / 2020已经排序（GISAID：EPI_ISL_751801）. 预期用途： NR-55245旨在用于分子测定或可用作过程（工作流程）对照（例如：通过QPCR扩增过程中的病毒RNA提取）.有关您的特定批次，请参阅灭活前传染性滴度和后灭活的基因组等当量（GE）量化的分析证书. GE由完全和部分基因组确定，并且是最终用户的估计，以限定他们平台上的测定.量化的产品也可用于制备稀释系列以估计检测水平.然而，该产品不适合作为全细胞抗原制剂，因为蛋白质含量主要由宿主细胞和病毒繁殖期间使用的胎牛血清贡献. 灭活程序：请参阅您从北部资源获得的大量物质的灭活测试分析证书.简而言之，测试了10％的灭活病毒以通过接种宿主细胞来证实残留活病毒的缺失.使用合适的对照，测试样品被传递两次，每篇通道孵育两周.在程序开发期间，通过测试残留活病毒的三个独立批次的100％来验证失活方案.注意：已知灭活过程损伤病毒RNA，并且不容易扩增大片段.该材料适用于检测小基因组片段的QPCR测定. 每个小瓶含有大约0.25ml的热灭活，澄清和稀释的细胞裂解物，并从感染SARS-COV-2的Vero E6细胞中上清液，分离USA / CA_CDC_5574 / 2020.小瓶应在开放前离心. 注意：此时不知道该准备的长期稳定性.建议用户在收到三个月内使用，确认产品的活动.您还可以联系Bei资源进行更新的稳定信息.

厂牌介绍

品牌标识

产品关键词

NR-55245_SARS 相关冠状病毒 2

隔离 USA/CA_CDC_5574/2020

一键获取大包装优惠报价

报价要求详细描述

贵单位贵姓

接受报价的E-mail

手机扫描二维码阅读本页

可能感兴趣的内容

2022-04-01

NR-47909金黄色葡萄球菌亚种.金黄色葡萄球菌,USA300JE2,转座子突变体SAUSA300_0137(NE1367)(突变细菌）

2021-12-13

2022-04-01

2024-06-05

2023-08-31

2022-04-01

2022-04-01

2022-04-01

2022-04-01

2022-04-01

2024-08-04

2022-04-01

2024-01-21

2021-12-21

2022-04-01

2024-11-17

2022-03-22

2024-02-29

CY5 DBCO,10毫克

2021-12-21

2021-10-31

NR-53530人类冠状病毒,NL63,热灭活(灭活生物体）

NR-53530_Human Coronavirus, NL63, Heat Inactivated(Inactivated Organisms)

产品图片

产品英文名称

产品别名

NR-53530_Human Coronavirus, NL63, Heat Inactivated(Inactivated Organisms)
NR-53530 人类冠状病毒，NL63，热灭活（灭活生物体）

货号/SKU

NR-53530

货号/规格

库存与交货期

3-8周

人民币价格

14000

人民币价格说明

本商品人民币2024年销售价格正在调整中，请等待更新完毕。

本商品的美元价、市场价、零售价、厂商指导价或该商品的曾经展示过的销售价等，并非商品原价，仅供参考。

试剂海关审批

A/B级风险物质只能直接使用人购买并持有实验室有效资质，其它询客服确认

国外采购

支持/部分限制一年内购买数量

厂牌

BEI Resources(ATCC)

品牌

产品基础信息

生物安全等级建议分类：美国、1

产品描述信息

NR-53530??Human Coronavirus, NL63, Heat Inactivated(Inactivated Organisms)|Human Coronavirus|NL63, Heat Inactivated|-60°C or colder|L van der HoekAcknowledgment for publications should read "The following reagent was obtained through BEI Resources, NIAID, NIH: Human Coronavirus, NL63, Heat Inactivated, NR-53530."|Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment.

NR-53530 is a preparation of human coronavirus (HCoV), NL63 that has been inactivated by heating to 65°C for 30 minutes and diluted prior to vialing.

HCoV, NL63 was isolated in 2003 from nasopharyngeal aspirate of human infant with acute respiratory disease in Amsterdam. The complete genome of HCoV, NL63 has been sequenced (GenBank: AY567487).

Each vial contains approximately 0.25 mL of heat inactivated, clarified and diluted cell lysate and supernatant from Macaca mulatta kidney epithelial cells infected with HCoV, NL63. The vial should be centrifuged prior to opening.

Note: The long-term stability of this preparation is not known at this time. It is recommended that users confirm the activity of the product if not used within three months of receipt. You may also contact BEI Resources for updated stability information.

主要内容

此项目的每个订单数量限制为1.此商品每年可订购两次.此限制的订单将在发货前发送到NIAID批准. NR-53530是人冠状病毒（HCOV），NL63的制备，其通过加热至65℃而已灭活30分钟并在瓶中稀释. HCOV，NL63于2003年患有阿姆斯特丹急性呼吸道疾病的鼻咽吸气. Hcov，NL63的完整基因组已被测序（Genbank： Ay567487 ）. 每个小瓶含有约0.25ml的热灭活，澄清和稀释的细胞裂解物和上清液从麦卡卡mulatta 肾上皮细胞感染Hcov，NL63.小瓶应在开放前离心. 注意：此时不知道该准备的长期稳定性.建议用户在收到三个月内使用，确认产品的活动.您还可以联系Bei资源进行更新的稳定信息.

厂牌介绍

品牌标识

产品关键词

NR-53530 人类冠状病毒

NL63

一键获取大包装优惠报价

报价要求详细描述

贵单位贵姓

接受报价的E-mail

手机扫描二维码阅读本页

可能感兴趣的内容

2022-04-01

NR-47909金黄色葡萄球菌亚种.金黄色葡萄球菌,USA300JE2,转座子突变体SAUSA300_0137(NE1367)(突变细菌）

2021-12-13

2022-04-01

2024-06-05

2023-08-31

2022-04-01

2022-04-01

2022-04-01

2022-04-01

2022-04-01

2024-08-04

2022-04-01

2024-01-21

2021-12-21

2022-04-01

2024-11-17

2022-03-22

2024-02-29

CY5 DBCO,10毫克

2021-12-21

2021-10-31

NR-52286_SARS相关冠状病毒2,隔离USA-WA1/2020,热灭活(灭活生物体）

NR-52286_ SARS-Related Coronavirus 2, Isolate USA-WA1/2020, Heat Inactivated(Inactivated Organisms)

产品图片

产品英文名称

产品别名

NR-52286_ SARS-Related Coronavirus 2, Isolate USA-WA1/2020, Heat Inactivated(Inactivated Organisms)
NR-52286_ SARS 相关冠状病毒 2，隔离 USA-WA1/2020，热灭活（灭活生物体）

货号/SKU

NR-52286

货号/规格

库存与交货期

3-8周

人民币价格

14000

人民币价格说明

本商品人民币2024年销售价格正在调整中，请等待更新完毕。

本商品的美元价、市场价、零售价、厂商指导价或该商品的曾经展示过的销售价等，并非商品原价，仅供参考。

试剂海关审批

A/B级风险物质只能直接使用人购买并持有实验室有效资质，其它询客服确认

国外采购

支持/部分限制一年内购买数量

厂牌

BEI Resources(ATCC)

品牌

产品基础信息

生物安全等级建议分类：美国、1

产品描述信息

NR-52286?? SARS-Related Coronavirus 2, Isolate USA-WA1/2020, Heat Inactivated(Inactivated Organisms)|SARS-Related Coronavirus 2|SARS-Related Coronavirus 2, Isolate USA-WA1/2020, Heat Inactivated|-60°C or colder|CDCAcknowledgment for publications should read "The following reagent was deposited by the Centers for Disease Control and Prevention and obtained through BEI Resources, NIAID, NIH: SARS-Related Coronavirus 2, Isolate USA-WA1/2020, Heat Inactivated, NR-52286."|Quantity limit per order for this item is 1. This item can be ordered twice a year. Orders over this limit will be sent to NIAID for approval before shipment.

NR-52286 is recommend for molecular assays. The current quality control testing for this item does not include immunological assays and it is not recommended that NR-52286 be used in this manner.

NR-52286 is a preparation of severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2), isolate USA-WA1/2020 that has been inactivated by heating to 65°C for 30 minutes and diluted prior to vialing.

SARS-CoV-2, isolate USA-WA1/2020 was isolated from an oropharyngeal swab from a patient with a respiratory illness who had recently returned from travel to the affected region of China and developed clinical disease (COVID-19) in January 2020 in Washington, USA.

The complete genome of SARS-CoV-2, USA-WA1/2020 has been sequenced from the isolate (GISAID: EPI_ISL_404895) and after one passage in Vero cells – GenBank: MT020880). The complete genome of SARS-CoV-2, USA-WA1/2020 has been sequenced after four passages in Vero cells in collaboration with Database for Reference Grade Microbial Sequences (FDA-ARGOS; GenBank: MT246667).

Intended Use:
NR-52286 is primarily intended for use in molecular assays or can be used as a process (work-flow) control (for example: viral RNA extraction through qPCR amplification process). Please refer to the Certificate of Analysis for pre-inactivation infectious titer and post-inactivated genome equivalence (GE) quantification by Droplet Digital PCR for your specific lot. The GE is determined by full and partial genomes and is an estimate for end-users to qualify assays on their platform and is subject to efficiency of RNA extraction. The estimated GE can also be used to make a dilution series to estimate level of detection. The heat inactivation procedure is known to damage viral RNA and large fragments are not easily amplified. The suitability of this product as a whole cell antigen preparation has not been assessed and may be influenced by the protein content largely contributed by the host cell and the fetal bovine serum used during virus propagation.

Inactivation Procedure:
Please refer to the Certificate of Analysis for the inactivation testing details.

Each vial contains approximately 0.25 mL of heat inactivated, clarified and diluted cell lysate and supernatant from Vero E6 cells infected with SARS-CoV-2, isolate USA-WA1/2020. The vial should be centrifuged prior to opening.

Note: The long-term stability of this preparation is not known at this time. It is recommended that users confirm the activity of the product if not used within three months of receipt. You may also contact BEI Resources for updated stability information.

主要内容

此项目的每个订单数量限制为1.此商品每年可订购两次.通过此限制的订单将在发货前发送至NIAID进行批准. 推荐NR-52286用于分子测定.该项目的当前质量控制测试不包括免疫测定，不建议以这种方式使用NR-52286. NR-52286是重症急性呼吸综合征相关的冠状病毒2（SARS-COV-2）的制备，分离出通过加热至65℃而灭活的US-WA1 / 2020 30分钟并在瓶中稀释. SARS-COV-2，孤立USA-WA1 / 2020从患有最近从旅行到中国受影响地区的呼吸疾病的口咽疾病中分离出来的患者，并在2020年1月开始出现临床疾病（Covid-19）华盛顿，美国. SARS-COV-2的完整基因组，USA-WA1 / 2020已从孤立（GISAID：EPI_ISL_404895）和VERO Cells中的一段通道后测序 - Genbank： mt020880 ）. SARS-CoV-2的完整基因组，USA-WA1 / 2020在与参考级微生物序列的数据库合作的vero细胞中的四次通道后已经测序（FDA-Argos; Genbank： mt246667 ）. 预期用途： NR-52286主要用于使用分子测定或可用作过程（工作流程）控制（例如：病毒RNA通过QPCR扩增过程提取）.请参考灭活前传染性滴度分析证书通过液滴数码PCR定量后失活的基因组当量（GE）量化为您的特定批次. GE由完全和部分基因组确定，是最终用户估算到他们平台上的测定并受到影响 RNA提取的效率.估计的GE也可以用来制作一个稀释系列以估计检测水平.热灭活程序已知损害病毒RNA，大片段不易扩增. ＆nbsp的适用性; 本产品作为整个细胞抗原制剂尚未评估，也可能是受蛋白质含量的影响大部分由宿主细胞和宿主细胞贡献病毒繁殖期间使用的胎牛血清.＆nbsp; ＆nbsp; 灭活程序：请参阅灭活测试细节分析证书.＆nbsp; 每个小瓶含有大约0.25ml的热灭活，澄清和稀释的细胞裂解物和来自感染SARS-COV-2的Vero E6细胞的上清液，隔离USA-WA1 / 2020.小瓶应在开放前离心. 注意：此时不知道该准备的长期稳定性.建议用户在收到三个月内使用，确认产品的活动.您还可以联系Bei资源以获取更新的稳定信息.

厂牌介绍

品牌标识

产品关键词

NR-52286_ SARS 相关冠状病毒 2

隔离 USA-WA1/2020

一键获取大包装优惠报价

报价要求详细描述

贵单位贵姓

接受报价的E-mail

手机扫描二维码阅读本页

可能感兴趣的内容

2022-04-01

NR-47909金黄色葡萄球菌亚种.金黄色葡萄球菌,USA300JE2,转座子突变体SAUSA300_0137(NE1367)(突变细菌）

2021-12-13

2022-04-01

2024-06-05

2023-08-31

2022-04-01

2022-04-01

2022-04-01

2022-04-01

2022-04-01

2024-08-04

2022-04-01

2024-01-21

2021-12-21

2022-04-01

2024-11-17

2022-03-22

2024-02-29

CY5 DBCO,10毫克

2021-12-21

2021-10-31

NR-50171中东呼吸综合征冠状病毒,EMC/2012,热灭活(灭活生物体）

NR-50171_Middle East Respiratory Syndrome Coronavirus, EMC/2012, Heat-Inactivated(Inactivated Organisms)

产品图片

产品英文名称

产品别名

NR-50171_Middle East Respiratory Syndrome Coronavirus, EMC/2012, Heat-Inactivated(Inactivated Organisms)
NR-50171 中东呼吸综合征冠状病毒，EMC/2012，热灭活（灭活生物体）

货号/SKU

NR-50171

货号/规格

库存与交货期

3-8周

人民币价格

14000

人民币价格说明

本商品人民币2024年销售价格正在调整中，请等待更新完毕。

本商品的美元价、市场价、零售价、厂商指导价或该商品的曾经展示过的销售价等，并非商品原价，仅供参考。

试剂海关审批

A/B级风险物质只能直接使用人购买并持有实验室有效资质，其它询客服确认

国外采购

支持/部分限制一年内购买数量

厂牌

BEI Resources(ATCC)

品牌